ABOUT KIMERA LABS
Leading the Future of Exosome Science
Our Mission
Exploring New Applications of Exosomes
Kimera Labs is dedicated to advancing the future of exosome biotechnology through scientific innovation, research, and the development of technologies that elevate cosmetic and research applications.
As Kimera Labs continues to advance exosome technology, we remain committed to expanding the scientific understanding of exosomes and their unique biological properties through ongoing research, innovation, and clinical investigation. By supporting scientific studies and developing next-generation exosome technologies, we strive to contribute meaningful discoveries that advance the field of exosome biotechnology.
The future of exosome science will be driven by continued innovation, deeper biological understanding, and advances in biotechnology that expand the possibilities of exosome applications. Kimera Labs is committed to helping shape that future through scientific discovery, technology development, and a relentless pursuit of excellence.
Kimera Labs Sets the Standard in Exosome Biotechnology
The leading exosome biotechnology laboratory advancing exosome science through innovation, precision manufacturing, and the development of MSC-derived technologies for cosmetic and research applications.
Founded in 2012 by Duncan Ross, Ph.D., Kimera Labs has been the leader in the field of MSC exosome production and isolation. Unlike biologic tissue laboratories that manufacture exosome products by direct processing of donor tissues such as adult bone marrow or placenta, Kimera Labs produces MSC exosomes from isolated mesenchymal stem cells cultures using chemically defined media, which contains no animal or human serum, following regulations laid out by the FDA.
Using advanced proprietary exosome isolation and manufacturing technologies, Kimera Labs develops high-purity MSC-derived exosome products at scale to support cosmetic innovation, scientific research, and future clinical development. Through rigorous quality standards, precision manufacturing, and continuous scientific advancement, we are helping expand the possibilities of exosome biotechnology.
By isolating and characterizing the naturally occurring biological signals contained within exosomes derived from perinatal mesenchymal stem cells, Kimera Labs is advancing the scientific understanding of their unique properties and potential applications. Through ongoing research, innovation, and collaboration, we remain committed to shaping the future of exosome science.
Quality
Optimal-Purity, Isolated Stem Cell Exosomes
To deliver the highest standards of quality, consistency, and scientific integrity, Kimera Labs has invested extensively in advanced exosome characterization, quality management systems, and cGMP manufacturing. Every production batch is manufactured and evaluated using rigorous analytical methods to ensure it meets established quality specifications.
Kimera Labs utilizes a comprehensive suite of advanced characterization technologies to verify the identity, purity, potency, and consistency of its exosome products. These include ELISA protein analysis, high-performance liquid chromatography (HPLC), RNA sequencing, Nanoparticle Tracking Analysis (NTA), atomic force microscopy (AFM), transmission electron microscopy (TEM), and dSTORM super-resolution fluorescence microscopy. Combined with robust quality management systems and batch-specific testing, these technologies help ensure the exceptional quality and consistency that define the Kimera standard.
Innovation
The Evolution of Exosome Technology
Kimera Labs continues to advance the science and production of MSC-derived exosome technologies through ongoing research, innovation, and manufacturing excellence. Operating from two adjacent state-of-the-art facilities featuring ISO Class 5 hoods and ISO Class 7 cleanrooms, our team is committed to developing the next generation of exosome technologies while maintaining the highest standards of quality and precision.
Through advanced exosome characterization, molecular analysis, and collaborative scientific research, Kimera Labs is expanding the understanding of exosome biology and its potential across cosmetic, research, diagnostic, and future clinical applications. Our scientists work alongside leading researchers and physicians to explore emerging technologies, including engineered exosomes, advanced biomarker discovery, and optimized delivery platforms, helping shape the future of exosome biotechnology.
Education
Advancing the Science of Tomorrow
As a global leader in exosome biotechnology, Kimera Labs is committed to advancing scientific knowledge through education, research, and innovation. We work closely with aesthetic professionals, researchers, scientists, and industry partners to expand the understanding of exosome science and support the responsible advancement of cosmetic, research, and future clinical applications.
Leadership comes with the responsibility to uphold scientific integrity. As the exosome industry continues to evolve, Kimera Labs remains dedicated to setting the highest standards for quality, transparency, and scientific validation. Through evidence-based research and educational initiatives, we strive to advance the field while fostering greater understanding of exosome technologies.
Located in Miramar, Florida, the Kimera Labs campus features a 27,000 sq. ft. exosome-dedicated innovation and manufacturing facility. Visitors have the opportunity to experience our advanced laboratories, explore our manufacturing and characterization capabilities, and learn about the latest developments in exosome science through guided facility tours, educational programs, scientific collaborations, and hands-on learning experiences.